PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
3.080
+0.010 (0.33%)
Aug 28, 2026, 4:00 PM EDT - Market closed
PepGen Market Cap
PepGen has a market cap or net worth of $213.32 million as of August 28, 2026. Its market cap has increased by 424.49% in one year.
Market Cap
213.32M
Enterprise Value
112.17M
1-Year Change
424.49%
Ranking
Category
Stock Price
$3.08
ChartMarket Cap Chart
Since May 6, 2022, PepGen's market cap has decreased from $288.65M to $213.32M, a decrease of -26.10%. That is a compound annual growth rate of -6.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 213.32M | -52.34% |
| Dec 31, 2025 | 447.55M | 262.28% |
| Dec 31, 2024 | 123.54M | -23.71% |
| Dec 29, 2023 | 161.93M | -48.75% |
| Dec 30, 2022 | 315.96M | 9.46% |
| May 6, 2022 | 288.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 218.69M |
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |
| Precision BioSciences | 214.74M |
| NovaBridge Biosciences | 213.44M |
| Acumen Pharmaceuticals | 211.17M |
| Corbus Pharmaceuticals Holdings | 211.01M |
| AN2 Therapeutics | 210.57M |